A Woman With Solar Urticaria and Heat Urticaria: A Unique Presentation of an Individual With Multiple Physical Urticarias
| Autor: | Philip R. Cohen, Antoanella Calame, Christof Erickson, Kyra L Diehl |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Solar urticaria photosensitivity Dermatology Omalizumab urticaria immune system diseases Heat stimulus parasitic diseases Biopsy Internal Medicine Pathology medicine skin and connective tissue diseases wheal Chronic urticaria integumentary system Angioedema medicine.diagnostic_test Heat urticaria business.industry angioedema Thyroid disease General Engineering medicine.disease erythematous histamine solar heat hive mast medicine.symptom business medicine.drug |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| DOI: | 10.7759/cureus.16950 |
| Popis: | Urticaria is a common group of dermatologic disorders characterized by hives. Solar urticaria and heat urticaria are two rare types of chronic inducible urticarias. Solar urticaria is triggered by exposure to sunlight or ultraviolet radiation. Heat urticaria is triggered by exposure or contact with a heat stimulus. A 63-year-old woman is described who has both solar urticaria and heat urticaria and the features of these chronic inducible urticarias are reviewed. The woman presented with urticarial lesions that appeared both after exposure to the sun and after cooking at a stove. Additional history revealed she was previously diagnosed with diabetes, hypertension, and thyroid disease. After sun exposure, a punch biopsy of both the affected skin, as well as the normal-appearing skin, was done. Correlation of the clinical history, cutaneous examination, and biopsy examination confirmed the diagnosis of solar urticaria. Treatment of the patient’s urticarias included histamine 1 (H1) and histamine 2 (H2) antihistamines. Her symptoms resolved and did not recur provided that she took the medication as prescribed. Management of chronic urticaria includes not only treatment of the current episode but also prevention of future recurring urticarial lesions. In addition to antihistamines, treatment may include omalizumab (Xolair®) injections for persistent urticaria. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|